joining me for more is riley griffin. obviously so much changing as we speak. the case of a company being too cautious or are we in for a rough few months? >> we know companies are closely following cdc data. forecasts of new reported covid-19 cases over the next four weeks are protected arise 350,000 to 1.8 million could hospitalizations as well which are mostly cropping up in unvaccinated pockets of america, new hospital admissions look like they are jumping by 6000 to 7000, all the way to 24,000. the data does not look good. we can look back to last year to tell the tale, it is typically when people shift away from the summer season and go indoors, temperatures get colder, cases rise. what we need to focus on is closing the gaps and getting the rest of the country vaccinated so that the virus stops mutating and being transmitted. emily: we are moving beyond six months from when vaccines first started being available. health officials still are not saying that boosters are necessary, but people like my mom, people of a certain age and health profile want to k

joining us is bloomberg health care reporter riley griffin. give us the details. ley: what does this mean? the biden administration and u.s. health officials are eager for this full approval. ultimately, they hope it increases confidence in the vaccine among hesitant americans. you've heard president biden say this is a pandemic of the unvaccinated. still three and 10 eligible americans have yet to get even one dose of a vaccine. the hope -- three in 10 eligible americans have yet to get even one dose of vaccine. the hope is that it will clear the way for employers, schools, and universities to begin mandating the vaccine with more comfort and confidence. we have not yet seen moderna, j&j approach u.s. regulators for that biologic license application. that process that facilitates full approval is different from the emergency use designation we have seen previously. that designation only lasts in public health emergencies during the state of the panda but, so this decision is ultimately critical not only to increasing confidence in the shot, but to ensuring that pf